D.A. Davidson & Co. Acelrx Pharmaceuticals Inc Transaction History

D.A. Davidson & Co.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 05, 2020	SELL	$0.76 - $2.07 $1,900 - $5,175	-2,500 Reduced 15.63%	13,500 $16,000
Q4 2019 Feb 14, 2020	SELL	$1.66 - $2.4 $51,460 - $74,400	-31,000 Reduced 65.96%	16,000 $34,000
Q4 2018 Jan 29, 2019	SELL	$2.13 - $4.8 $43,665 - $98,400	-20,500 Reduced 30.37%	47,000 $109,000
Q3 2018 Nov 13, 2018	BUY	$2.6 - $4.6 $10,400 - $18,400	4,000 Added 6.3%	67,500 $260,000
Q3 2017 Nov 08, 2017	BUY	$2.9 - $4.6 $4,640 - $7,359	1,600 Added 2.58%	63,500 $292,000
Q2 2017 Aug 11, 2017	BUY	N/A	61,900	61,900 $0

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.